KIROMIC
Dead / Abandoned — Abandoned — no statement of use filed (as of 28 Aug 2023)
What this means for you
This application is over — abandoned 28 Aug 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97484071
- Mark type
- Stylized text
- Filed
- 30 Jun 2022
- Published for opposition
- 29 Nov 2022
- Abandoned
- 28 Aug 2023
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, biologic, and biopharmaceutical preparations for use in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations, cell therapies, and gene therapies for preventing, managing, and treating diseases and disorders in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Biological compounds in the nature of human cells used for enhanced delivery of therapeutic agents to targeted cells within the human body; Biological components, namely, engineered and edited human cells, being a component in therapeutic preparations for use in diseases and disorders of oncology, immunology, and immune-oncology; Therapeutic preparations in the nature of cell therapies for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for destroying tumor cells and inhibiting tumor growth; Human cells for medical and therapeutic use; T-cells for medical and therapeutic use
Owner
- Kiromic Biopharma, Inc., Houston, TX, US
- Kiromic Biopharma, Inc., Houston, TX, US
Prosecution history
- 28 Aug 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 28 Aug 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Jan 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Nov 2022 — PUBLISHED FOR OPPOSITION
- 09 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Oct 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Oct 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Oct 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Oct 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Oct 2022 — NON-FINAL ACTION E-MAILED
- 05 Oct 2022 — NON-FINAL ACTION WRITTEN
- 03 Oct 2022 — ASSIGNED TO EXAMINER
- 20 Jul 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED